Diagnostic Diabetes Predictor
A supervised classification benchmark evaluating logistic regression, support vector machines, and random forests on clinical metabolic markers for early diabetes risk identification.
Project Overview
Type-2 diabetes frequently remains undetected during early glycemic shifts, causing insidious microvascular and cardiovascular damage before a formal clinical diagnosis is rendered.
This diagnostic pipeline performs rigorous comparative analysis across standard supervised statistical learning models on metabolic indicators (fasting blood glucose, insulin, body mass index, age, and diabetes pedigree function). The project rigorously evaluates trade-offs between model interpretability and predictive power, delivering validated screening recommendations.
Key Features
Comparative Benchmark Suite
Benchmarked Logistic Regression, RBF-kernel SVM, Random Forests, and k-NN under uniform cross-validation folds.
Outlier & Zero-Value Treatment
Replaced biologically implausible zero-value records (e.g. 0 mm skinfold or 0 mg/dL blood pressure) with median imputation stratified by age bracket.
Threshold Tuning for Sensitivity
Optimized classification decision thresholds to minimize false-negative rates, prioritizing clinical patient safety in diagnostic screening.
Feature Importance Analysis
Quantified Gini impurity reduction and coefficient odds ratios to confirm glucose concentration and BMI as premier diagnostic indicators.